Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study.

Donati, Simone; Yang, Chang-Hao; Xu, Xun; Mura, Marco; Giocanti-Aurégan, Audrey; Hoerauf, Hans; Allmeier, Helmut; Machewitz, Tobias; Johnson, Kristian T; Santoro, Elina

Donati, Simone; Yang, Chang-Hao; Xu, Xun; Mura, Marco; Giocanti-Aurégan, Audrey; Hoerauf, Hans; Allmeier, Helmut; Machewitz, Tobias; Johnson, Kristian T; Santoro, Elina.

Afiliación

Donati S; Department of Medicine and Surgery, University of Insubria, Via Guicciardini 9, 21100, Varese, Italy. simone.donati@uninsubria.it.
Yang CH; Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Xu X; College of Medicine, National Taiwan University, Taipei, Taiwan.
Mura M; Department of Ophthalmology, Shanghai General Hospital, Shanghai, China.
Giocanti-Aurégan A; King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Hoerauf H; Hôpital Avicenne, Sorbonne Paris Nord University, Bobigny, France.
Allmeier H; Augenklinik, Universitätsmedizin Göttingen, Göttingen, Germany.
Machewitz T; Bayer Consumer Care AG, Basel, Switzerland.
Johnson KT; Bayer AG, Berlin, Germany.
Santoro E; Bayer U.S. LLC, Cambridge, MA, USA.

Ophthalmol Ther ; 13(1): 161-178, 2024 Jan.

Article en En | MEDLINE | ID: mdl-37924483

Palabras clave

Anti-vascular endothelial growth factor; Diabetes; Diabetic macular edema; Diabetic retinopathy; Intravitreal aflibercept; Observational study; Real-world evidence; Retinal disease

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Ophthalmol Ther Año: 2024 Tipo del documento: Article País de afiliación: Italia